Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-041736
Filing Date
2017-06-23
Accepted
2017-06-23 17:35:12
Documents
1
Period of Report
2017-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5713
  Complete submission text file 0001209191-17-041736.txt   7195
Mailing Address SPRINT NEXTEL CORPORATION 2001 EDMUND HALLEY DRIVE RESTON VA 20191
Business Address
Hockaday Irvine O Jr (Reporting) CIK: 0001113487 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35952 | Film No.: 17928523

Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Issuer) CIK: 0001509190 (see all company filings)

EIN.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations